Funded Tech Companies
Thryv Therapeutics
Thryv Therapeutics is a leading biopharmaceutical tech company, based in Montreal, Quebec. VC investment came from Alexandria Venture Investments, InClin and Lumira Ventures.
Company Overview
Company Name
Thryv Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
999 Boulevard De Maisonneuve Ouest 1250
Montreal, Quebec, H3A 3L4
CA
Montreal, Quebec, H3A 3L4
CA
Phone
Website
Email Address
Company Background Information
Overview
Thryv Therapeutics is a clinical-stage biotechnology company developing precision medicines for inherited cardiac arrhythmias, cardiometabolic diseases and cardiomyopathies. The company develops selective SGK1 inhibitors, including its lead drug candidate THRV-1268, which is being evaluated in clinical trials.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/3/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Truex
Chief Medical Officer
Amy Sehnert
Company Investors
- Alexandria Venture Investments
- InClin
- Lumira Ventures
- CTI Life Sciences Fund
- Amplitude Ventures
- adMare BioInnovations
- Fonds de solidarite FTQ
- Investissement Quebec
Browse more funded tech companies:
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs